TrialBMJ (Clinical research ed.)2026

Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial.

Shun-Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.